2nd DSTU Draft For Comment

This page is part of the FHIR Specification (v0.4.0: DSTU 2 Draft). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R4 R3 R2

V3-substanceAdminSubstitution.xml

Raw XML (canonical form)

Identifies what sort of change is permitted or has occurred between the therapy that was ordered and the therapy that was/will be provided.

Raw XML

<ValueSet xmlns="http://hl7.org/fhir">
  <id value="v3-substanceAdminSubstitution"/>
  <meta>
    <lastUpdated value="2014-12-11T00:00:00.000+11:00"/>
    <profile value="http://hl7.org/fhir/Profile/valueset-shareable-definition"/>
  </meta>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><!-- Snipped for brevity --></div>
  </text>
  <url value="http://hl7.org/fhir/v3/vs/substanceAdminSubstitution"/>
  <version value="2014-12-11"/>
  <name value="v3 Code System substanceAdminSubstitution"/>
  <publisher value="HL7, Inc"/>
  <contact>
    <telecom>
      <system value="url"/>
      <value value="http://hl7.org"/>
    </telecom>
  </contact>
  <description value=" Identifies what sort of change is permitted or has occurred between the therapy that
     was ordered and the therapy that was/will be provided."/>
  <status value="active"/>
  <experimental value="false"/>
  <date value="2014-12-11"/>
  <define>
    <extension url="http://hl7.org/fhir/ExtensionDefinition/valueset-oid">
      <valueUri value="urn:oid:2.16.840.1.113883.5.1070"/>
    </extension>
    <system value="http://hl7.org/fhir/v3/substanceAdminSubstitution"/>
    <caseSensitive value="true"/>
    <concept>
      <code value="_ActSubstanceAdminSubstitutionCode"/>
      <abstract value="true"/>
      <display value="ActSubstanceAdminSubstitutionCode"/>
      <definition value="Description: Substitution occurred or is permitted with another product that may potentially
         have different ingredients, but having the same biological and therapeutic effects."/>
      <concept>
        <code value="E"/>
        <abstract value="false"/>
        <display value="equivalent"/>
        <definition value="Description: Substitution occurred or is permitted with another bioequivalent and therapeutically
           equivalent product."/>
        <concept>
          <code value="EC"/>
          <abstract value="false"/>
          <display value="equivalent composition"/>
          <definition value="Description:                                                    Substitution occurred
             or is permitted with another product that is a:                                      
                            pharmaceutical alternative containing the same active ingredient but is
             formulated with different salt, ester                            pharmaceutical equivalent
             that has the same active ingredient, strength, dosage form and route of administration
                                                                                          Examples:
                                                                                                  
                                     Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin
             Stearate                                                           Pharmaceutical equivalent:
             Lisonpril for Zestril"/>
          <concept>
            <code value="BC"/>
            <abstract value="false"/>
            <display value="brand composition"/>
            <definition value="Description:                                                    Substitution occurred
               or is permitted between equivalent Brands but not Generics                           
                                         Examples:                                                  
                                            Zestril  for Prinivil                            Coumadin
               for Jantoven"/>
          </concept>
          <concept>
            <code value="G"/>
            <abstract value="false"/>
            <display value="generic composition"/>
            <definition value="Description: Substitution occurred or is permitted between equivalent Generics but not
               Brands                                                      Examples:                
                                                                              Lisnopril (Lupin Corp)
               for Lisnopril (Wockhardt Corp)"/>
          </concept>
        </concept>
        <concept>
          <code value="TE"/>
          <abstract value="false"/>
          <display value="therapeutic alternative"/>
          <definition value="Description: Substitution occurred or is permitted with another product having the same
             therapeutic objective and safety profile.                                            
                      Examples:                                                                   
                         ranitidine for Tagamet"/>
          <concept>
            <code value="TB"/>
            <abstract value="false"/>
            <display value="therapeutic brand"/>
            <definition value="Description: Substitution occurred or is permitted between therapeutically equivalent
               Brands but not Generics &gt;                            Examples:                    
                                                                          Zantac for Tagamet"/>
          </concept>
          <concept>
            <code value="TG"/>
            <abstract value="false"/>
            <display value="therapeutic generic"/>
            <definition value="Description: Substitution occurred or is permitted between therapeutically equivalent
               Generics but not Brands &gt;                            Examples:                    
                                                                          Ranitidine  for cimetidine"/>
          </concept>
        </concept>
      </concept>
      <concept>
        <code value="F"/>
        <abstract value="false"/>
        <display value="formulary"/>
        <definition value="Description: This substitution was performed or is permitted based on formulary guidelines."/>
      </concept>
      <concept>
        <code value="N"/>
        <abstract value="false"/>
        <display value="none"/>
        <definition value="No substitution occurred or is permitted."/>
      </concept>
    </concept>
  </define>
</ValueSet>

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.